We previously found that SHIP2 overexpression suppresses the Akt prosurvival signaling pathway and enhances podocyte apoptosis (10), and thus, upregulation of SHIP2 expression or activity might contribute to insulin resistance and loss of podocytes in DKD. This evidence concerns the gene AKT1 and diabetic kidney disease.